PPARA and intestinal cancer: Our results demonstrate that inhibition of Wnt/β-catenin signaling increased, while activation of Wnt/β-catenin pathway decreased, the expression and transcriptional activity of PPARγ, but not PPARα, in intestinal cancer cell lines.